REGN5678 trials for Prostate cancer

All REGN5678 trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying REGN5678 for Prostate cancer

• A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
  NCT06826768 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy
  NCT06085664 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
  NCT05125016 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 14 locations
• A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
  NCT03972657 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 24 locations

Common questions

How many trials study REGN5678 for Prostate cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.